Ibata, S., Sato, T., Kuroda, H., Nagamachi, Y., Iyama, S., Fujimi, A., . . . Kato, J. (2016). A phase II trial of small-dose bortezomib, lenalidomide and dexamethasone (sVRD) as consolidation/maintenance therapy in patients with multiple myeloma. Cancer Chemother Pharmacol.
Citação norma ChicagoIbata, Soushi, et al. "A Phase II Trial of Small-dose Bortezomib, Lenalidomide and Dexamethasone (sVRD) As Consolidation/maintenance Therapy in Patients With Multiple Myeloma." Cancer Chemother Pharmacol 2016.
Citação norma MLAIbata, Soushi, et al. "A Phase II Trial of Small-dose Bortezomib, Lenalidomide and Dexamethasone (sVRD) As Consolidation/maintenance Therapy in Patients With Multiple Myeloma." Cancer Chemother Pharmacol 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.